If Ozempic is too expensive, out of stock, hard to tolerate, or simply not approved for weight loss where you are, you have more alternatives in Canada than ever — and several of them actually work better. The strongest alternative is tirzepatide (Mounjaro/Zepbound). The cheapest are the new generics. The most convenient are the pills.
Here is every real option compared — what it is, how it stacks up, and the honest truth about “natural Ozempic” (spoiler: it is not equivalent).
Why look for an alternative
The usual reasons: cost (weight-loss use is rarely covered in Canada), supply shortages, gastrointestinal side effects, needle aversion, or the fact that Ozempic itself is approved for diabetes rather than weight loss. The good news is the field has exploded — what was a one-drug conversation three years ago is now a whole menu. For the big-picture map, start with the complete GLP-1 drugs guide.
The best Ozempic alternative is not a secret — it is tirzepatide, which beat semaglutide head-to-head. The cheapest is whichever generic your pharmacy now stocks.The two answers most people are actually looking for
The alternatives compared
| Alternative | What it is | Avg weight loss | Why choose it |
|---|---|---|---|
| Wegovy | Semaglutide, obesity-approved | ~15% | On-label weight-loss version of Ozempic’s molecule |
| Mounjaro / Zepbound | Tirzepatide (GLP-1 + GIP) | ~20% | Strongest approved option; beat semaglutide head-to-head |
| Oral semaglutide (Wegovy pill) | Semaglutide tablet | ~15% | No needles |
| Orforglipron | Oral small-molecule GLP-1 | ~11% | Pill, easier to scale, newer |
| Saxenda | Liraglutide (daily) | ~8% | Older, well-understood |
| Generics | Generic semaglutide / Sevmia | Same as brand | Cheapest route |
| Retatrutide | Triple agonist (investigational) | ~28% | Most potent — but not approved |
Deeper dives: Mounjaro vs Ozempic, Wegovy vs Zepbound, the Wegovy pill, orforglipron, and retatrutide’s results.
The cheaper routes
Price is the number-one reason people look elsewhere, and 2026 finally brought relief. A generic Ozempic and the first generic Wegovy (Sevmia) have entered the Canadian market, which puts downward pressure on prices across the board. Oral options can also be cheaper to produce at scale. The honest caveat: “cheaper” still means a real prescription drug from a pharmacy — not a grey-market vial. See generic Ozempic in Canada, Sevmia and weight-loss injections in Canada.
What about “natural Ozempic”?
You will see berberine sold as “nature’s Ozempic” and all manner of supplements promising the same effect. Be realistic: none of them comes close to a GLP-1 drug. Berberine has modest effects on blood sugar and weight in some studies, but it is not a GLP-1 agonist and does not produce double-digit percentage weight loss. “Natural alternative” is a marketing frame, not a clinical equivalent. If your goal is the kind of loss seen in the trials, the alternatives that deliver it are other GLP-1 drugs, not a supplement.
Every effective alternative here is a prescription medicine. Which one fits — and at what dose — is a decision for your doctor. This article is background, not dosing guidance or a recommendation.
The research-compound angle
Some of these molecules — tirzepatide, retatrutide, cagrilintide — also exist as research peptides, sold by labs including TrueLabs (tirzepatide as TZ-2, retatrutide as RT3). These are raw compounds for in vitro and laboratory study, not approved medicines or an “alternative” you can substitute for a prescription — no verified dose, formulation or oversight. For sourcing context, see Canadian vs imported peptides.
Ozempic-alternative myths
“Myth: There is nothing as good as Ozempic.”
Tirzepatide out-performed semaglutide head-to-head, and retatrutide’s trial numbers are higher still. Ozempic is no longer the strongest option.
“Myth: Berberine is natural Ozempic.”
It is not a GLP-1 drug and does not produce comparable weight loss. The “natural” label is marketing.
“Myth: Generics are weaker.”
A generic contains the same active molecule as the brand and works the same. It is simply cheaper.
“Myth: A research peptide is a legit cheaper alternative.”
No. It is an unapproved raw compound for lab use, not a substitute for a prescribed medicine.
For researchers
TrueLabs supplies TZ-2 (tirzepatide) from $73, RT3 (retatrutide) from $90 and Cagrilintide from $40, in CAD for in vitro and laboratory research only. Before ordering, see how to read a peptide COA and the COA library.
FAQ
Tap a question to reveal the answer.
What is the best alternative to Ozempic?
For weight loss, tirzepatide (Mounjaro/Zepbound) is the strongest approved alternative — it beat semaglutide head-to-head at about 20% versus 14%. The investigational retatrutide is higher still but not approved.
Is there a cheaper alternative to Ozempic in Canada?
Yes. A generic Ozempic and the first generic Wegovy (Sevmia) have entered the Canadian market, lowering prices. Oral options may also be cheaper. All are still prescription drugs.
What is a natural alternative to Ozempic?
There is no true natural equivalent. Supplements like berberine have modest effects but are not GLP-1 drugs and do not produce comparable weight loss.
Is Wegovy the same as Ozempic?
Same molecule (semaglutide), different brand and dose range. Wegovy is approved for weight management; Ozempic for diabetes.
Are there Ozempic alternatives in pill form?
Yes. Oral semaglutide (the Wegovy pill) and the new small-molecule orforglipron are oral options, generally with somewhat less weight loss than the strongest injectables.
Is a research peptide a valid Ozempic alternative?
No. Research peptides are unapproved raw compounds for laboratory use, without verified dose, formulation or oversight. They are not substitutes for a prescribed drug.
Which alternative has the fewest side effects?
All GLP-1 drugs share mainly gastrointestinal effects. Lower-potency options like liraglutide may be gentler but also produce less weight loss. It is an individual trade-off to discuss with a doctor.
What is coming next?
Retatrutide (triple agonist), CagriSema, survodutide and more oral small molecules are in the pipeline, several more potent than today’s approved drugs.
Related reading
- The complete GLP-1 drugs guide
- Mounjaro vs Ozempic
- Generic Ozempic in Canada
- Next weight-loss drugs after Ozempic
- Weight-loss injections in Canada
References
- Aronne LJ, et al. Tirzepatide versus Semaglutide for the Treatment of Obesity (SURMOUNT-5). N Engl J Med. 2025. NEJM
- Wilding JPH, et al. Once-Weekly Semaglutide (STEP-1). N Engl J Med. 2021;384:989-1002. NEJM
- Jastreboff AM, et al. Tirzepatide for Obesity (SURMOUNT-1). N Engl J Med. 2022;387:205-216. NEJM
This article summarizes published research and regulatory information for information only and is not medical advice. TrueLabs research compounds are sold for in vitro and laboratory research use only and are not intended for human or veterinary use.